Copyright
©The Author(s) 2015.
World J Methodol. Jun 26, 2015; 5(2): 68-87
Published online Jun 26, 2015. doi: 10.5662/wjm.v5.i2.68
Published online Jun 26, 2015. doi: 10.5662/wjm.v5.i2.68
Table 1 International Consensus Criteria for myalgic encephalomyelitis[18]
Post-exertional neuro-immune exhaustion: |
A pathological inability to produce sufficient energy on demand with prominent symptoms primarily in the neuroimmune regions |
Neurological impairments |
At least one symptom from three of the following four symptom categories: Cognitive impairments (information processing and short-term memory) |
Pain (e.g., headache, muscle, joint, abdominal and/or chest pain) |
Sleep disturbance (disturbed sleep patterns and unrefreshing sleep) |
Neurosensory, perceptual and motor disturbances |
Immune, gastro-intestinal and genitourinary impairments |
At least one symptom from three of the following five symptom categories: |
Flu-like symptoms, e.g., sore throat and tender lymph nodes |
Susceptibility to viral infections with prolonged recovery periods |
Gastro-intestinal tract complaints, e.g., irritable bowel syndrome |
Genitourinary complaints: e.g., nocturia |
Sensitivities to food, medications, odours or chemicals |
Energy production and - transportation impairments |
At least one of the following four symptoms: |
Cardiovascular symptoms, e.g., (delayed) orthostatic intolerance |
Respiratory problems, e.g., air hunger and fatigue of chest wall muscles |
Loss of thermostatic stability, e.g., sweating episodes or feverish feeling |
Intolerance of extremes of temperature |
Table 2 Fukuda et al[19] Diagnostic Criteria for chronic fatigue syndrome
Primary symptom: |
Clinically evaluated, unexplained, persistent or relapsing chronic fatigue |
That is of new or definite onset; is not the result of ongoing exertion |
That is not substantially alleviated by rest; and |
That results in substantial reduction in previous levels of occupational, educational, social, or personal activities |
Secondary symptoms: |
The concurrent occurrence of four or more of the following symptoms, all of which must have persisted or recurred during 6 or more consecutive months of illness and must not have predated the fatigue: |
Self-reported impairment in short-term memory or concentration severe enough to cause substantial reduction in previous levels of occupational, educational, social, or personal activities |
Sore throat |
Tender cervical or axillary lymph nodes |
Muscle pain |
Multi-joint pain without joint swelling or redness |
Headaches of a new type, pattern, or severity |
Unrefreshing sleep |
Post-exertional malaise lasting more than 24 h |
Table 3 Empirical case definition for chronic fatigue (syndrome)[47]
Fatigue: |
A score |
≥ 13 (out of 20) on the general fatigue or |
≥ 10 (out of 20) on the reduced activity |
subscales of the multidimensional fatigue inventory[56] |
Functional impairment: |
A score |
≤ 70 (out of 100) on the physical function, or |
≤ 50 (out of 100) on role physical, or |
≤ 75 (out of 100) on the social function, or |
≤ 66.7 (out of 100) on the role emotional |
subscales of the medical outcomes survey short form-36 (SF-36)[11] |
Secondary symptoms: |
≥ 4 of the following 8 symptoms: |
Impaired memory or concentration |
Unrefreshing sleep |
Headaches |
Muscle pain |
Joint pain |
Sore throat |
Tender cervical nodes and |
Unusual post exertional fatigue |
And A score of ≥ 25 (out of 128) |
On the Symptom Inventory Case Definition subscale[57] |
Table 4 Symptoms and tests to assess the disability in myalgic encephalomyelitis/chronic fatigue syndrome objectively
Symptoms | Tests | Ref. |
Lack of energy: physical weakness and ”fatigue” | CPET 1: workload and oxygen uptake at exhaustion and at the anaerobic threshold | [62,63] |
Cognitive impairment | Specific neuropsychological tests | [64-67] |
Post-exertional "malaise” | ||
Physical effects | Repeated CPETs 1, 24 h apart | |
Cognitive effects | Specific neuropsychological tests | |
before and after a CPET or | ||
before and during a tilt table test | ||
Repeated neuropsychological tests | ||
Muscle weakness | Examination of the muscles (power, endurance, recovery) | [68-71] |
Orthostatic intolerance | Tilt-table test | [72-74] |
Defective stress response | Hormonal investigation (HPA axis, thyroid) in rest, at specific moments, e.g., at wakening, and during the day, after provocation, e.g., by adrenocorticotropic hormone and insulin, and in response to an exercise test or psychological stress test | [75-78] |
Sleep impairment | Polysomnographic investigation (EEG) | [79-81] |
Maintenance of wakefulness test | [79,82,83] | |
Multiple sleep latency test | [79,82,83] | |
Visual symptoms | Useful field of view tests | [84,85] |
Eye movement tests | [86,87] |
Table 5 Adverse effects of a CPET (CPET1) on the performance levels at a second CPET (CPET2) 24 h later: An example
CPET Day 1 | CPET Day 2 | |
Rest | ||
Heart rate | 88 | 80 |
Oxygen uptake (VO2min) | 6 | 6 |
Anaerobic threshold | ||
Heart rate (HR AT) | 105 | 89 |
Oxygen uptake (VO2 AT) | 11 | 9 |
Workload (W AT) | 54 | 35 |
Exhaustion | ||
Heart rate (HRmax) | 151 | 131 |
Oxygen uptake (VO2max) | 23 | 22 |
Workload (Wmax) | 159 | 133 |
Table 6 Manifestations of orthostatic cardiovascular abnormalities
Abnormality | Definition |
Orthostatic systolic hypotension | A fall in the systolic blood pressure of 20 mmHg or more[74,193] |
Orthostatic diastolic hypotension | A fall in the diastolic blood pressure of 10 mmHg or more[74,193] |
Orthostatic diastolic hypertension | A rise in dBP to 98 mmHg or more[74] |
Orthostatic postural tachycardia | An increase in heart rate of 28[74]/30[194] beats per minute (bpm) or a pulse of more than 110[74]/120[194] bpm |
Orthostatic narrowing of pulse pressure | A fall in the pulse pressure to 18 mmHg or less[74] |
- Citation: Twisk FN. Accurate diagnosis of myalgic encephalomyelitis and chronic fatigue syndrome based upon objective test methods for characteristic symptoms. World J Methodol 2015; 5(2): 68-87
- URL: https://www.wjgnet.com/2222-0682/full/v5/i2/68.htm
- DOI: https://dx.doi.org/10.5662/wjm.v5.i2.68